| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |